Interestingly, several in vivo/in vitro pharmacologic experiments and molecular docking simulations suggested that CBD could also inhibit the EGFR/AKT/MMPs signaling pathway, triggering programmed cell death, inhibiting angiogenesis, and reducing tumour growth and metastasis in different mouse models and tumour cell types [69,70,71,72]. Here, AKT1 is linked to neoplasm.